Allergies News and Research

Latest Allergies News and Research

NIR spectroscopy offers fast, easy, inexpensive way to detect food allergens

Food allergies pose a significant health risk, resulting in numerous hospitalizations every year, as even trace amounts of allergens can trigger severe reactions.

18 May 2023

New study reveals a revolutionary approach to studying airborne genetic material

Recently published in PeerJ Life and Environment, researchers successfully use aircraft surveys with novel instrumentation to capture airborne nucleic acids and probe biodiversity in the atmosphere, uncovering surprising findings.

15 May 2023

Phase 1 trial of experimental universal influenza vaccine begins enrolling volunteers

A clinical trial of an experimental universal influenza vaccine developed by researchers at the National Institute of Allergy and Infectious Diseases' (NIAID) Vaccine Research Center (VRC), part of the National Institutes of Health, has begun enrolling volunteers at Duke University in Durham, North Carolina.

15 May 2023

First-in-human clinical trial tests experimental oral drug for removing radioactive contaminants

A first-in-human clinical trial of an experimental oral drug for removing radioactive contaminants from inside the body has begun.

15 May 2023

Robo-diets: can ChatGPT formulate safe dietary advice?

Researchers investigate the accuracy and safety of ‘robo-diets’.

15 May 2023

Study indicates that patients diagnosed with allergic rhinitis have lower risk of periodontitis

Researchers examined associations between periodontitis and allergic rhinitis (AR).

10 May 2023

UCF researcher develops a new, more precise treatment for acute respiratory viral infections

A University of Central Florida College of Medicine researcher has developed a new, more precise treatment for a major cause of illness around the world each year - acute respiratory viral infections.

9 May 2023

Understanding Lupus: an interview with the Garvan Institute

To commemorate World Lupus Day, we spoke to Elissa Deenick, co-lead of the Precision Immunology Program at the Garvan Institute, about the current state of lupus understanding and what needs to happen to make lupus visible.

9 May 2023

AI tools can help simplify a test that works for hepatitis C and SARS-CoV-2

Going beyond pregnancy and COVID-19, the world could someday soon come to rely on at-home tests for many diseases thanks in part to AI-fueled improvements.

8 May 2023

Cancer-fighting immune cells can fuel their ability to attack tumors

When you need a bit of motivation, it often has to come from within. New research suggests cancer-fighting immune cells have found a way to do just that.

8 May 2023

Hay fever could be triggering other allergies, doctor reveals

Hay fever may be triggering an allergic reaction to foods such as fruits, vegetables, nuts and legumes, a doctor from a digital healthcare provider has revealed.

8 May 2023

Women with a history of domestic abuse may have higher risk of atopic diseases

Women who have suffered domestic abuse may have a higher risk of developing atopic diseases including asthma, new research has found.

6 May 2023

New guidance recommends the discontinuation of antibiotics after closure of incisions

Antibiotics administered before and during surgery should be discontinued immediately after a patient's incision is closed, according to updated recommendations for preventing surgical site infections.

5 May 2023

Health programs are at risk as debt ceiling cave-in looms

The partisan fight in Congress over how to raise the nation's debt ceiling to prevent a default has accelerated, as the U.S. Treasury predicted the borrowing limit could be reached as soon as June 1.

4 May 2023

NIH researchers gain new insights on rare immune deficiency

In an 11-year study, researchers at the National Institutes of Health have further characterized idiopathic CD4 lymphocytopenia (ICL), a rare immune deficiency that leaves people vulnerable to infectious diseases, autoimmune diseases and cancers.

4 May 2023

Discontinuing oral antibiotics after breast reconstruction does not lead to an increase in infections

For breast cancer patients undergoing breast reconstruction after mastectomy, avoiding postoperative oral antibiotics does not reduce the risk of infections, reports a study in the May issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons.

27 Apr 2023

Allergies News and Research

Latest Allergies News and Research

NIR spectroscopy offers fast, easy, inexpensive way to detect food allergens

New study reveals a revolutionary approach to studying airborne genetic material

Phase 1 trial of experimental universal influenza vaccine begins enrolling volunteers

First-in-human clinical trial tests experimental oral drug for removing radioactive contaminants

Robo-diets: can ChatGPT formulate safe dietary advice?

Study indicates that patients diagnosed with allergic rhinitis have lower risk of periodontitis

UCF researcher develops a new, more precise treatment for acute respiratory viral infections

Understanding Lupus: an interview with the Garvan Institute

AI tools can help simplify a test that works for hepatitis C and SARS-CoV-2

Cancer-fighting immune cells can fuel their ability to attack tumors

Hay fever could be triggering other allergies, doctor reveals

Women with a history of domestic abuse may have higher risk of atopic diseases

New guidance recommends the discontinuation of antibiotics after closure of incisions

Health programs are at risk as debt ceiling cave-in looms

NIH researchers gain new insights on rare immune deficiency

Discontinuing oral antibiotics after breast reconstruction does not lead to an increase in infections

Colchicine therapy benefits pediatric long COVID patients suffering from recurring fever

Does maternal peanut consumption protect against infant peanut allergies?

New class of immunotherapy shows promise against aggressive skin cancer

RSV infection in the first year of life associated with increased risk of childhood asthma

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Allergies News and Research

Latest Allergies News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in